Özdemir, EKakehi, YOkuno, HYoshida, O2024-04-242024-04-2419990022-5347https://doi.org/10.1016/S0022-5347(01)61684-7https://hdl.handle.net/11468/16233Purpose: This study was conducted to clarify which matrix metalloproteinases (MMPs) play a key role in destruction of the underlying basement membrane (BM) of superficial urothelial carcinomas. Urine concentrations of MMP-9 and tissue inhibitors of matrix metalloproteinase-l (TIMP-1) were also measured. Materials and Methods: Overexpression of MMP-1, MMP-2 and MMP-9 was analyzed immunohistochemically in 60 patients with transitional cell carcinomas of the urothelium (41 were pTa or pis, 19 were pT(1-4)), and compared them with type IV collagen expression in tumor BM. In 33 of them, urine concentrations of MMP-9 and TIMP-1 were measured by one-step sandwich enzyme immunoassay. Results: Positive expression of MMP-1, MMP-2 and MMP-9 was found in 53%, 17%, and 65% of tumors, respectively. Only MMP-9 expression rates were increased with grades and stages (p = 0.03). In pTa and pis tumors, type IV collagen expression was reduced in 17 of 26 (65.4%), and it was associated with positive MMP-9 expression (p = 0.0283). MMP-9 was detected in all urine samples of urothelial cancer patients, while urine TIMP-1 was detectable in 18 of 33 patients. In 16 healthy volunteers, both of them were below detectable levels, Balance between urinary MMP-9 and TIMP-1 were particularly kept in superficial urothelial carcinomas with intact tumor BM. Tumor BM: status, however, was not associated with urinary MMP-9 or TIMP-1 levels. Conclusions: These results suggest that MMP-9 plays a key role in the invasion step of superficial urothelial carcinomas. Detection of urinary MMP-9 may become a new, non-invasive mean for the diagnosis of urothelial carcinomas.eninfo:eu-repo/semantics/closedAccessSuperficial Urothelial CarcinomasMatrix MetalloproteinasesTissue Inhibitors Of Matrix Metalloproteinase-1Type Iv CollagenArticle161413591363WOS:0000790140000941008190810.1016/S0022-5347(01)61684-7Q1